ClinicalTrials.gg
CompletedNCT01918293Updated Nov 27, 2013

Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma): Adult

An interventional study of SMART ARM in BRONCHIAL ASTHMA, sponsored by Inje University. Completed at 1 site in South Korea. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2013-11-27.

Sponsored by Inje University · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Bronchial asthma is an chronic airway disease with bronchial hypersensitivity due to inflammation and bronchial muscle contraction. It can cause recurrent dyspnea, cough, wheezing and severe life-threatening attack and lower quality of life. In addition, it make large amount of socioeconomic loss as about 3.7 billion US dollars.

02

Conditions studied

  • BRONCHIAL ASTHMA

Browse trials for

Keywords

  • ASTHMA
  • SMARTPHONE APPLICATION
03

In context

Asthma

4,012 studies on the registry are indexed under Asthma; 514 are open to participants now.

This study's enrollment of 60 is below the median of 83 across 2,814 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

Inje University is the lead sponsor of 93 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • using smartphone
  • alleged bronchial asthma over 3months \& positive of bronchodilator response test or bronchial provocation test

Exclusion criteria

Exclusion Criteria:

  • COPD
  • active pulmonary TUBERCULOSIS
  • Acute exacerbation within 4weeks
  • severe psychological disorder
  • severe systemic disease; severe LC, ESRD ...
  • MALIGNANCY
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    SMART arm

    Using smartphone application for control of asthma

    Device: SMART ARM

  • No intervention
    conventional arm

    non-using smartphone application for control asthma

Interventions

  • DeviceSMART ARM

    The smartphone application for self-management of Asthma offers symptom diary, general information for asthma, the information of asthma drugs,the guideline for inhaler and the specific action plan according to daily symptom and FEV1.

    Also known as: SMART-Asthma

06

What researchers measure

Primary outcomes

  1. The efficacy of smartphone application for asthma control test (ACT)and quality of life

    Using ACT and ALQL score (QoL), we will investigate the efficacy of smanrtphone application for control of asthma compared to smartphone app. using group and smartphone app. non-using group

    Time frame: at least 2 times a week

Secondary outcomes

  1. FEV1 (Forced expiratory volume in 1 second ) and FVC (Forced vital capacity)

    Using spirometer to check the variation of FEV1,we will investigate the efficacy of smanrtphone application for control of asthma compared to smartphone app. using group and smartphone app. non-using group

    Time frame: at least 1 time a month

  2. Acute exacerbation of bronchial asthma

    Using medical record and questionaire of acute exacerbation,we will investigate the efficacy of smanrtphone application for control of asthma compared to smartphone app. using group and smartphone app. non-using group

    Time frame: at least 1 time a week

07

Study locations

1 site
  • Haeundae Paik Hospital
    Busan, 612-896, South Korea
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01918293
Lead sponsor
Inje University
Responsible party
Jongha Park (Study principal investigator, Inje University) — Principal investigator
First posted
Aug 7, 2013
Start date
Sep 2012
Primary completion
Sep 2013
Completion
Oct 2013
Last update
Nov 27, 2013

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion